Results 141 to 150 of about 1,690 (152)

Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort

Nutrition, Metabolism and Cardiovascular Diseases, 2016
Maurizio Averna, A B Cefalù, Claudia Stefanutti   +2 more
exaly  

<p>Lomitapide: a review of its clinical use, efficacy, and tolerability</p>

Core Evidence, 2019
Rodrigo Alonso, Pedro Mata
exaly  

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Journal of Atherosclerosis and Thrombosis, 2019
Atsushi Nohara, Masayuki Yoshida, Mariko Harada-Shiba   +2 more
exaly  

Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children.

The Lancet Diabetes and Endocrinology
L. Brunham, R. Hegele
semanticscholar   +1 more source

The long-term, real-world effectiveness and safety of lomitapide in homozygous familial hypercholesterolaemia (HoFH): Nine-year data from the lomitapide observational worldwide evaluation registry (lower)

Atherosclerosis
Dirk Blom, J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Sallyann O’Brien   +5 more
semanticscholar   +1 more source

The Lomitapide Observational Worldwide Evaluation Registry (LOWER) - Nine-year Effectiveness and Safety Data in HoFH

Journal of Clinical Lipidology
J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Sallyann O’Brien, Dirk Blom   +5 more
semanticscholar   +1 more source

Lomitapide/warfarin

Reactions weekly

semanticscholar   +1 more source

Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – analysis of patient-level LDL-C reduction, fat soluble vitamins, lipoproteins and patient maturation from APH-19 study

Atherosclerosis
Lluís Masana, Alberto Zambon, C. Schmitt, Christina Taylan, Joenna Dreimeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Naji Kholaif, Sandra Löwe, Zsuzsanna Tamas   +15 more
semanticscholar   +1 more source

299 (PB287): Lomitapide enhances cytotoxic effects of temozolomide in chemoresistant glioblastoma

European Journal of Cancer
A. Ivanova, T. Wilson, K. Ghannad-Zadeh, E. Tse, M. Wu, S. Das   +5 more
semanticscholar   +1 more source

LOMITAPIDE PHASE-3 STUDY IN PEDIATRIC HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): APH-19

Atherosclerosis
Naji Kholaif, Luis Masana, Alberto Zambon, C. Schmitt, Christina Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, Mohammad Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Sandra Lowe, Zsuzsanna Tamas   +15 more
semanticscholar   +1 more source